Servier Egypt launches Tibsovo as first targeted therapy for IDH1-mutated cancers
[Daily News Egypt - Egypt] - 10/12/2025
Servier Egypt has launched Tibsovo (ivosidenib), the first targeted therapy available in the country for patients with IDH1-mutated Acute Myeloid Leukemia (AML) and intrahepatic cholangiocarcinoma. The new treatment offers a median overall survival of 29.3 months for eligible AML patients and (…)
... Article published by "Daily News Egypt" (Egypt), read more
For any information or claim on this article, see directly with the newspaper.
In Egyptian newspapers
President Sisi affirms importance of educational partnership with Japan
CAIRO, Dec 6 (MENA) – President Abdel Fattah al-Sisi affirmed the importance of Egypt’s educational partnership with (…)
[Egypt Independent] - 8/12/2025
Egyptian Novelist Salwa Bakr Wins First BRICS Literary Prize
Egyptian writer Salwa Bakr was announced on Monday, 1 December, as the inaugural winner of the BRICS Literary Prize, (…)
[Egyptian Streets] - 2/12/2025
Egypt’s tax revenues rise by EGP 600bn as private sector boosts investment in FY 2024/25
Finance Minister Ahmed Kouchouk said the private sector’s strong response to the government’s tax-relief initiative (…)
[Daily News Egypt] - 7/12/2025
The Platform Making Egypt’s Blue-Collar Workers Feel Seen and Paid Fairly
The moment you walk into a café and place an order for a coffee, your mind naturally jumps straight to the final (…)
[Egyptian Streets] - 2/12/2025
KABO for clothing boosts daily capacity to 85,000 pieces, expands to 78 production lines
El Nasr Clothing and Textiles Company (KABO) announced the rollout of a comprehensive development and expansion plan (…)
[Daily News Egypt] - 7/12/2025
